BRIEF-Cadrenal Therapeutics Says Matthew Szot Steps Down As CFO - SEC Filing
Cadrenal Therapeutics, Inc.
Cadrenal Therapeutics, Inc. CVKD | 0.00 |
June 3 (Reuters) - Cadrenal Therapeutics Inc CVKD.O:
CADRENAL THERAPEUTICS - MATTHEW K. SZOT STEPS DOWN AS CFO EFFECTIVE MAY 28, 2026 - SEC FILING
CADRENAL THERAPEUTICS - APPOINTS QUANG X. PHAM AS INTERIM CFO AND INTERIM PRINCIPAL ACCOUNTING OFFICER - SEC FILING
Source text: [ID:n0001213900-26-064744]
Further company coverage: CVKD.O
